Gonadotropin treatment of hypogonadotropic hypogonadal adolescents

Citation
C. Bouvattier et al., Gonadotropin treatment of hypogonadotropic hypogonadal adolescents, J PED END M, 12, 1999, pp. 339-344
Citations number
18
Categorie Soggetti
Endocrinology, Nutrition & Metabolism
Journal title
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM
ISSN journal
0334018X → ACNP
Volume
12
Year of publication
1999
Supplement
1
Pages
339 - 344
Database
ISI
SICI code
0334-018X(199904)12:<339:GTOHHA>2.0.ZU;2-4
Abstract
Testosterone substitution, needed for normal physical development in male h ypogonadal adolescents, does not induce testicular growth. We treated 37 hy pogonadal adolescents with gonadotropins (hCG/hMG), to obtain complete viri lization during the first two years of treatment, to avoid psychological se quellae and to allow normal sexual development. Testicular volume increased significantly during therapy (from 1.98 +/- 1.2 to 9 +/- 3.3 mi), while te stosterone rose from 0.26 +/- 0.04 to 5.3 +/- 0.8 ng/ml, with worse results in adolescents with cryptorchidism. hCG/hMG treatment had a better outcome than testosterone during the induction of puberty, avoiding psychological problems induced by atrophic testes. Further long term studies are necessar y to evaluate whether early hCG/hMG treatment facilitates later spermatogen esis even in patients with cryptorchidism.